Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.51p
   
  • Change Today:
    -0.042p
  • 52 Week High: 17.25
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 401.31m
  • Volume: 741,812
  • Market Cap: £6.05m
  • Beta: 0.01

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2144.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 9.8 n/a
Pr/Book 0.5  
Latest F'cast
Revenue -41.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Belluscura Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.98) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.42 (5.21) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 1.40 (8.15) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.82 (18.52) (14.20)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Belluscura Company Announcements

Holding(s) in Company 27-Mar-2025 15:15 RNS
Holding(s) in Company 10-Mar-2025 17:49 RNS
Holding(s) in Company 06-Mar-2025 16:21 RNS

Belluscura ShareCast News

Belluscura launches £0.5m retail offer alongside... 07-Feb-2025 ShareCast
Belluscura US subsidiary secures $4m credit faci... 22-Nov-2024 ShareCast
Belluscura group revenues continue to grow YTD 28-Oct-2024 ShareCast

Latest Belluscura Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Belluscura Market Data

Currency UK Pounds
Share Price 1.51p
Change Today -0.042p
% Change -2.73 %
52 Week High 17.25
52 Week Low 1.50
Volume 741,812
Shares Issued 401.31m
Market Cap £6.05m
Beta 0.01

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.69% above the market average66.69% above the market average66.69% above the market average66.69% above the market average66.69% above the market average
93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average
Price Trend
99.01% below the market average99.01% below the market average99.01% below the market average99.01% below the market average99.01% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
3.23% below the market average3.23% below the market average3.23% below the market average3.23% below the market average3.23% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

Belluscura Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
11:15 500,000 @ 1.55p
10:39 100,000 @ 1.50p
10:32 23 @ 1.50p
10:23 6,353 @ 1.57p
09:40 44,011 @ 1.51p

Belluscura Key Personnel

CEO Robert “Bob” Rauker
CFO Simon Neicheril

Top of Page